Hints and tips:
Related Special Reports
...The website is part of an effort by pharma companies to sell drugs directly to patients and simplify a system for distributing medication that is facing growing criticism for its complexity....
...People are increasingly turning to TikTok, Instagram and other social media platforms for medical advice and information, partly driven by a lack of direct access to healthcare professionals and a desire...
...“There is still a lot of work to complete in order to increase patient access and make cannabis a first line treatment under the current medical program in Germany.”...
...The early-stage plans are the latest effort by a pharmaceutical company to circumvent industry middlemen and sell drugs directly to US patients....
...Patients require regular MRI scans to monitor for potentially dangerous side-effects such as brain bleeds. Other regulators, including the UK’s MHRA, have not yet approved the drug....
...The advisory panel is likely to opine on which specific patients should be able to access the treatment....
...In April, access to Enhertu in England was blocked on value-for-money grounds although it got a green light in Scotland. Investors should also worry that the market is getting overcrowded....
...Shortages are at a record high and have been for some time for patients suffering from conditions such as diabetes, Parkinson’s, ADHD, asthma, multiple sclerosis, HRT, tuberculosis, and antibiotics....
...For patients, shortages ultimately translate into less effective treatment....
...Patients with terminal breast cancer in England will be denied access to a new treatment that has already been approved in Scotland, after a public health body said the drug did not provide value for money...
...Among his patients suffering from it, up to half improved after taking a nasal spray derivative of ketamine, which is approved for use in many countries....
...So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some young patients by up to 45 years....
...The push into prescriptions and drug delivery is unusual for a pharmaceutical manufacturer, pitting Eli Lilly against pharmacies such as CVS and Walgreens....
...Eli Lilly last week announced a deal to buy a Wisconsin-based production facility for filling its injectable pens from Nexus Pharmaceuticals....
...In contrast, pharmaceutical companies raised just $160mn for antibiotic research, a decline over the decade. Commercial activity and research in antibiotics have been in decline since the 1980s....
...Touissant said the combined shot would offer patients “enhanced convenience and protection against two serious respiratory viruses”....
...important therapy for eligible patients with early-onset MLD in the US”....
...But Knudson said the number of new Wegovy patients would need to keep increasing in order for Novo Nordisk to meet sales targets for the year....
...global standard of care for patients,” said Shockwave president and chief executive Doug Godshall....
...For every woman, that’s about 500 days, or around a year-and-a-half of her life....
...In 2017, he oversaw the launch of the international Coalition for Epidemic Preparedness Innovations (Cepi), which now has a pivotal role in efforts to tackle the next pandemic threat posed by an as yet unknown...
...the first pharmaceutical treatment for the underlying disease,” said Emmick....
...The push into prescriptions and drug delivery is unusual for a pharmaceutical manufacturer, pitting Eli Lilly against US pharmacy chains such as CVS and Walgreens. Read more here...
...But this is a slow process requiring Israel’s agreement to the exit of patients and their accompanying family members....
...The announcement comes after the pharmaceutical group requested in March that the European Union marketing authorisation for Vaxzevria be withdrawn, a request that was granted on Tuesday....
International Edition